Please assess the completion status of the following clinical trial:

Trial Title: SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* HIV infection~* Receiving Kaletra, stavudine, and lamivudine for greater than 6 years (through Abbott M97-720 study)~* Planning to switch from stavudine to tenofovir~Exclusion Criteria:~* Will continue to receive stavudine

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).